Holding BBP?
Track your performance easily

BBP Price & Analysis

BBP ETF Chart & Stats

Day’s Range― - ―
52-Week Range$44.72 - $55.62
Previous Close$49.11
VolumeN/A
Average Volume (3M)1.78K
AUM14.72M
NAV49.11
Expense Ratio0.79%
Holdings Count55
Beta0.84
Inception DateDec 17, 2014
Dividend YieldN/A
Shares Outstanding350,004
Standard Deviation0.07
10 Day Avg. Volume852
30 Day Avg. Volume1,779
Alpha-0.00174

BBP ETF FAQ

What was BBP’s price range in the past 12 months?
BBP lowest ETF price was $44.72 and its highest was $55.62 in the past 12 months.
    What is the AUM of BBP?
    As of Oct 17, 2023 The AUM of BBP is 14.72M.
      Is BBP overvalued?
      According to Wall Street analysts BBP’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does BBP pay dividends?
        BBP pays a Notavailable dividend of $0.07 which represents an annual dividend yield of N/A. See more information on BBP dividends here
          How many shares outstanding does BBP have?
          BBP has 350,004 shares outstanding.
            Which hedge fund is a major shareholder of BBP?
            Currently, no hedge funds are holding shares in BBP

            BBP ETF Smart Score

            For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

            Top 10 Holdings

            Name
            Weight %
            Bridgebio Pharma
            3.22%
            Intercept Pharmaceuticals Inc
            3.15%
            Rhythm Pharmaceuticals
            2.94%
            Amgen Inc
            2.68%
            Insmed
            2.68%
            Neurocrine Biosciences
            2.49%
            Ionis Pharmaceuticals Inc.
            2.45%
            Exelixis
            2.37%
            Halozyme Therapeutics
            2.31%
            Vertex Pharmaceuticals Inc.
            2.27%
            Total26.56%

            ETF Description

            Virtus LifeSci Biotech Products ETF

            BBP tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider.
            Sector
            Sector
            Asset Class
            Equity
            Region
            North America
            Issuer
            Virtus
            Index Tracked
            LifeSci Biotechnology Products Index
            Ticker Symbol
            BBP

            Popular ETFs

            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis